Kingsley I. Ndoh holds a medical degree from the University of Jos and an MPH in Global Health from the University of Washington. In his role at BIO Ventures for Global Health, he led the first ever access agreement for affordable cancer medicines between the Nigerian government and leading pharmaceutical companies. He is a Clinical Assistant Professor at the UW Department of Global Health and an Affiliate Member of the Vaccines and Infectious Disease Division at the Fred Hutchinson Cancer Center. He is also a member of the Technical Working Committee of the W.H.O’s Global Breast Cancer Initiative (GBCI) and a Union for International Cancer Control (UICC) Young Leader alumnus. Kingsley is additionally the Founder & Chief Strategist of Hurone AI – a digital health startup focused on bridging the gaps of cancer care and improving outcomes by building culturally sensitive artificial intelligence applications to make high quality cancer care accessible to people all around the world.